• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Liminatus Pharma, Inc. - Class A Common Stock (NQ:LIMN)

2.660 +0.140 (+5.56%)
Delayed Quote Updated: 11:34 AM EST, Nov 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 35,341
Open 2.630
Bid (Size) 2.550 (100)
Ask (Size) 2.770 (100)
Prev. Close 2.520
Today's Range 2.404 - 2.770
52wk Range 2.520 - 141.50
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price Rule
September 29, 2026
From Liminatus Pharma Inc.
Via GlobeNewswire
News headline image
Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy
August 24, 2026
Engagement advances clinical execution of IBC101, Liminatus’ CD19xCD22 bivalent CAR-T therapy for relapsed or refractory B-cell malignancies 
From Liminatus Pharma Inc.
Via GlobeNewswire

Performance

52-Week Range 98.1% below 52-week high
2.660
2.5252W Low 141.5052W High
1 Week 15.3% below 1-week high
2.521W Low 3.141W High

Liminatus Pharma, Inc. - Class A Common Stock (LIMN) traded between $2.52 and $141.50 over the past 52 weeks and last traded at $2.66, 98.1% below its 52-week high. Over the past week it ranged between $2.52 and $3.14.

Past 12 Months
-8.0%
-33.3%
-53.2%
-75.0%
-91.7%
-96.0%
1W -$0.23
1M -$1.33
3M -$3.02
6M -$7.99
YTD -$29.37
1Y -$63.34

LIMN was -96.0% over the past year, -75.0% over six months, -91.7% year to date, -8.0% in the last week.

12 Months vs Market
LIMN
-96.0%
DIA
+9.1%
SPY
+10.5%
QQQ
+8.7%
IWM
+14.5%

Over the past 12 months LIMN returned -96.0% versus DIA (Dow) +9.1%, SPY (S&P 500) +10.5%, QQQ (Nasdaq 100) +8.7% and IWM (Russell 2000) +14.5%.

Volume & Liquidity 0.16× 3-mo avg
Today 35,341 3-mo avg 218.7K
1W
20.2K
1M
25.4K
3M
218.7K
6M
413.5K
YTD
316.4K
1Y
265.4K

LIMN most recently traded 35,341 shares against a 3-month average daily volume of 218.7K.

More News

Read More
News headline image
Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock
August 18, 2026
From Liminatus Pharma Inc.
Via GlobeNewswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
August 13, 2026
Via Chartmill
Thursday's session: most active stocks ↗
July 02, 2026
Via Chartmill
These stocks are the most active in today's session ↗
August 13, 2026
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
August 13, 2026
Via Benzinga
Let's take a look at the stocks that are in motion in today's session. ↗
August 13, 2026
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
August 13, 2026
Via Chartmill
These stocks are moving in today's pre-market session ↗
August 13, 2026
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
August 13, 2026
Via Benzinga
News headline image
Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement
August 13, 2026
From Liminatus Pharma Inc.
Via GlobeNewswire
What's going on in today's pre-market session ↗
July 17, 2026
Via Chartmill
Thursday's after hours session: top gainers and losers ↗
July 16, 2026
Via Chartmill
What's going on in today's session ↗
July 16, 2026
Via Chartmill
Curious about the most active stocks on Thursday? ↗
July 16, 2026
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
July 16, 2026
Via Benzinga
Thursday's session: top gainers and losers ↗
July 16, 2026
Via Chartmill
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
July 16, 2026
Via Chartmill
These stocks are making the most noise in today's session. ↗
July 06, 2026
Via Chartmill
Unusual volume stocks are being observed in Monday's session. ↗
July 06, 2026
Via Chartmill
News headline image
11 Health Care Stocks Moving In Thursday's Intraday Session ↗
July 02, 2026
Via Benzinga
Top movers in Thursday's session ↗
July 02, 2026
Via Chartmill
Thursday's session: gap up and gap down stocks ↗
July 02, 2026
Via Chartmill
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
July 02, 2026
Via Chartmill

Frequently Asked Questions

Is Liminatus Pharma, Inc. - Class A Common Stock publicly traded?
Yes, Liminatus Pharma, Inc. - Class A Common Stock is publicly traded.
What exchange does Liminatus Pharma, Inc. - Class A Common Stock trade on?
Liminatus Pharma, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Liminatus Pharma, Inc. - Class A Common Stock?
The ticker symbol for Liminatus Pharma, Inc. - Class A Common Stock is LIMN on the Nasdaq Stock Market
What is the current price of Liminatus Pharma, Inc. - Class A Common Stock?
The current price of Liminatus Pharma, Inc. - Class A Common Stock is 2.660
When was Liminatus Pharma, Inc. - Class A Common Stock last traded?
The last trade of Liminatus Pharma, Inc. - Class A Common Stock was at 11/03/26 11:34 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap